stori
emerg
sever
acut
respiratori
syndrom
sar
familiar
physician
new
coronaviru
caus
agent
genet
sequenc
determin
experiment
model
infect
develop
speed
knowledg
acquir
unpreced
develop
provid
basi
announc
earli
april
research
nation
institut
health
unit
state
begun
develop
sar
vaccin
soon
thereaft
us
secretari
health
human
servic
conven
meet
execut
repres
vaccin
compani
enlist
particip
effort
investig
compani
western
europ
sinc
announc
similar
initi
recent
dr
juli
gerberd
director
center
diseas
control
prevent
atlanta
ga
wrote
reason
optimist
futur
control
measur
vaccin
success
prevent
coronaviru
infect
anim
develop
effect
vaccin
new
coronaviru
realist
possibl
p
howev
achiev
goal
may
difficult
inactiv
viru
vaccin
would
easiest
quickest
develop
inactiv
respiratori
syncyti
viru
measl
vaccin
caus
exacerb
natur
ill
suggest
clinic
ill
sarsinfect
patient
might
due
much
host
respons
infect
infect
liveattenu
viru
vaccin
anoth
possibl
coronavirus
genet
unstabl
concern
danger
mutant
virus
could
evolv
whatev
type
sar
vaccin
develop
demonstr
safeti
human
challeng
commentari
dr
gerberd
ask
make
product
avail
fast
enough
prevent
extens
global
outbreak
recent
experi
advanc
measur
bioterror
suggest
pace
develop
dramat
acceler
howev
potenti
ratelimit
step
includ
time
resourc
need
increas
vaccin
product
meet
global
market
need
p
editori
new
scientist
put
succinctli
could
even
develop
vaccin
record
time
past
histori
anyth
go
vaccin
sold
high
price
rich
get
poor
nt
sober
remind
current
vaccin
first
introduc
develop
countri
mani
year
trickl
develop
countri
thing
happen
sar
vaccin
world
health
organ
depart
vaccin
biolog
propos
new
categori
call
emerg
respons
vaccin
vaccin
direct
sporad
epidem
eg
yellow
fever
group
meningococc
mening
subsaharan
africa
pandem
infect
influenza
occur
routin
potenti
caus
catastroph
level
infect
worldwid
global
threat
due
noncircul
pathogen
eg
smallpox
viru
novel
pathogen
eg
sar
viru
unknown
potenti
rapid
transmiss
sever
health
consequ
ensur
adequ
suppli
emerg
respons
vaccin
call
upon
intern
public
sector
develop
mechan
longterm
develop
forecast
number
dose
need
know
certainti
come
develop
regulatori
standard
global
registr
develop
financi
mechan
procur
polici
alloc
although
report
address
intern
commun
analysi
recommend
need
consid
serious
nation
health
offici
gener
first
respond
challeng
provid
vaccin
vaccin
compani
execut
met
us
secretari
health
human
servic
one
repres
compani
locat
develop
countri
given
rapid
sar
stori
evolv
understand
nonetheless
sar
demonstr
potenti
involv
countri
reason
vaccin
compani
develop
countri
must
becom
involv
develop
product
sar
vaccin
understand
import
look
current
sourc
suppli
routin
childhood
vaccin
develop
countri
million
million
dose
measlescontain
vaccin
produc
world
produc
develop
countri
michel
zaffran
person
commun
next
year
monoval
measl
vaccin
purchas
unit
nation
children
fund
unicef
probabl
come
either
india
indonesia
michel
zaffran
person
commun
whoprequalifi
vaccin
produc
standard
produc
develop
countri
produc
sar
vaccin
requir
use
cell
cultur
facil
vaccin
manufactur
develop
countri
use
compani
work
isol
belong
develop
countri
vaccin
manufactur
network
dcvmn
dcvmn
aim
provid
consist
sustain
suppli
qualiti
vaccin
afford
price
develop
countri
activ
engag
unicef
world
bank
global
allianc
vaccin
immun
well
ministri
health
foundat
nongovernment
organ
involv
nation
immun
program
thu
vaccin
compani
develop
countri
well
posit
becom
activ
engag
global
plan
product
sar
vaccin
issu
outlin
accompani
articl
issu
global
suppli
pandem
influenza
vaccin
overlap
sar
vaccin
develop
safe
vaccin
seed
strain
perhap
mean
revers
genet
essenti
first
step
publicli
fund
immunogen
safeti
trial
sar
vaccin
must
includ
vaccin
produc
compani
develop
countri
global
registr
process
must
develop
allow
sar
vaccin
produc
countri
sent
need
health
ministri
must
defin
target
popul
sar
vaccin
nation
vaccin
demand
forecast
must
aggreg
global
level
vaccin
compani
clear
idea
mani
dose
call
upon
produc
unavoid
problem
financ
alloc
countri
produc
afford
sar
vaccin
must
confront
directli
import
recogn
manner
problem
address
resolv
provid
good
indic
similar
problem
manag
next
threat
influenza
pandem
appear
comment
problem
suppli
vaccin
rich
poor
countri
new
scientist
note
might
sad
old
problem
one
need
think
sens
justic
pure
selfinterest
econom
disloc
caus
sar
alreadi
immens
asian
develop
bank
estim
sar
could
end
cost
asian
countri
billion
estim
put
global
cost
billion
whether
econom
consequ
sar
driven
fear
realist
assess
risk
immateri
damag
everyon
see
influenza
pandem
may
differ
thu
sar
pandem
influenza
vaccin
alik
race
stake
high
outcom
predict
p
